Cognyte Software Ltd.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Net income (loss) $12.3m $27.4m $20.3m ($10.3m) ($110.0m) ($11.6m) ($7.2m) $4.6m
Depreciation and amortization $21.0m $17.3m $22.5m $21.3m $18.1m $13.8m $13.7m $12.0m
Benefit from deferred income taxes $9.0m $5.6m ($2.2m) $5.9m $45k ($3.2m) ($1.4m) ($2.0m)
Gain from business divestiture, see Note 7 $0 $0 ($5.8m) ($4.8m) $0 $0
Allowance for credit losses $1.9m $1.4m $1.9m $432k $2.8m $2.5m $1.4m $718k
Stock-based compensation, excluding cash-settled awards $25.5m $31.0m $27.4m $32.9m $25.2m $12.2m $19.0m $21.2m
Non-cash (gains) losses on derivative financial instruments, net ($726k) ($395k) $95k ($133k) $426k $330k ($179k) ($595k)
Other non-cash items, net $409k $1.7m ($3.0m) $766k $681k ($685k) $32k $1.1m
Accounts receivable ($44.1m) ($24.1m) $1.5m ($5.7m) $59.2m $12.4m $10.6m ($6.3m)
Contract assets $21.6m $17.7m $8.4m ($7.1m) $8.5m ($7.3m) ($6.7m) ($1.8m)
Inventories ($3.6m) ($392k) ($1.1m) ($363k) ($13.1m) ($960k) $4.6m $2.4m
Prepaid expenses and other assets $1.6m $7.0m $5.1m $8.5m ($2.4m) $5.3m ($7.8m) $5.3m
Accounts payable and accrued expenses ($7.8m) $1.3m $8.7m $4.9m ($37.9m) $4.3m $14.3m $10.5m
Contract liabilities $30.0m $9.3m ($16.8m) ($51.3m) $18.0m $13.9m $8.0m ($8.9m)
Other liabilities ($10.2m) ($20.8m) $210k $1.8m $174k ($2.9m) ($1.6m) $944k
Other, net $965k ($1.4m) $1.9m $1.4m ($1.0m) $1.3m $101k $957k
Purchases of property and equipment ($9.9m) ($13.7m) ($14.2m) ($11.8m) ($8.3m) ($7.0m) ($10.6m) ($10.4m)
Settlements of derivative financial instruments not designated as hedges $126k $212k $213k ($138k) $201k ($977k) $117k $623k
Cash paid for capitalized software development costs ($2.7m) ($7.6m) ($5.1m) ($6.0m) ($3.4m) ($2.0m) ($2.6m) ($243k)
Change in restricted bank time deposits, including long-term portion ($21.8m) ($14.2m) $31.1m $5.6m $358k ($2.8m) $2.4m $200k
Purchases of treasury stock $0 $0 ($5.3m) ($21.4m)
Repayment of principal portion of finance lease liability $0 $0 ($99k) ($298k)
Restricted cash and cash equivalents included in other assets $2.4m $7.8m $10.2m $2.1m $163k $94k $0 $0
Net cash provided by operating activities $53.7m $67.2m $71.3m $2.6m ($37.0m) $34.6m $46.8m $40.3m
Acquisition of business, net of cash acquired ($3.8m) ($18.7m) $0 $0 ($4.3m)
Purchases of short-term investments ($57.7m) ($29.1m) ($48.6m) ($59.0m) ($55.1m) ($58.7m) $0 $0
Maturities of short-term investments $28.2m $53.5m $51.2m $53.0m $48.8m $75.9m $0 $0
Proceeds from Business divestiture, net of cost $0 $0 $37.6m $5.0m $4.9m $0
Net cash (used in) provided by investing activities ($68.3m) ($29.5m) $16.4m ($17.9m) $20.1m $9.4m ($5.7m) ($14.1m)
Dividends paid to noncontrolling interest ($4.4m) ($4.3m) ($4.2m) ($3.3m) ($2.9m) ($2.5m) ($2.6m) ($3.1m)
Net cash used in financing activities $6.1m ($86.0m) ($205.6m) $58.7m ($102.9m) ($2.5m) ($8.0m) ($24.8m)
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents ($9.1m) ($49.3m) ($118.8m) $43.6m ($119.2m) $41.4m $32.5m $4.0m
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents ($544k) ($985k) ($864k) $41k $617k ($115k) ($631k) $2.6m
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period $282.7m $233.4m $114.7m $158.2m $39.0m $80.4m $112.9m $116.9m
Cash and cash equivalents $240.2m $201.1m $78.6m $152.6m $34.6m $74.5m $112.7m $116.9m
Restricted cash and cash equivalents included in restricted cash and cash equivalents and restricted bank time deposits $40.2m $24.5m $25.9m $3.5m $4.3m $5.8m $185k $0